These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32074247)

  • 1. An Appraisal of the Association of Clinical Outcomes With the Severity of Regurgitant Volume Relative to End-Diastolic Volume in Patients With Secondary Mitral Regurgitation.
    Gaasch WH; Aurigemma GP; Meyer TE
    JAMA Cardiol; 2020 Apr; 5(4):476-481. PubMed ID: 32074247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Effective Regurgitation Orifice Area to Left Ventricular End-Diastolic Volume Ratio With Transcatheter Mitral Valve Repair Outcomes: A Secondary Analysis of the COAPT Trial.
    Lindenfeld J; Abraham WT; Grayburn PA; Kar S; Asch FM; Lim DS; Nie H; Singhal P; Sundareswaran KS; Weissman NJ; Mack MJ; Stone GW;
    JAMA Cardiol; 2021 Apr; 6(4):427-436. PubMed ID: 33533873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials.
    Anker SD; Friede T; von Bardeleben RS; Butler J; Khan MS; Diek M; Heinrich J; Geyer M; Placzek M; Ferrari R; Abraham WT; Alfieri O; Auricchio A; Bayes-Genis A; Cleland JGF; Filippatos G; Gustafsson F; Haverkamp W; Kelm M; Kuck KH; Landmesser U; Maggioni AP; Metra M; Ninios V; Petrie MC; Rassaf T; Ruschitzka F; Schäfer U; Schulze PC; Spargias K; Vahanian A; Zamorano JL; Zeiher A; Karakas M; Koehler F; Lainscak M; Öner A; Mezilis N; Theofilogiannakos EK; Ninios I; Chrissoheris M; Kourkoveli P; Papadopoulos K; Smolka G; Wojakowski W; Reczuch K; Pinto FJ; Zmudka K; Kalarus Z; Adamo M; Santiago-Vacas E; Ruf TF; Gross M; Tongers J; Hasenfuß G; Schillinger W; Ponikowski P
    Eur J Heart Fail; 2024 Jul; 26(7):1608-1615. PubMed ID: 38847420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proportionate and Disproportionate Functional Mitral Regurgitation: A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials.
    Grayburn PA; Sannino A; Packer M
    JACC Cardiovasc Imaging; 2019 Feb; 12(2):353-362. PubMed ID: 30553663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Mitral Regurgitation Severity and Left Ventricular Remodeling on Outcome After MitraClip Implantation: Results From the Mitra-FR Trial.
    Messika-Zeitoun D; Iung B; Armoiry X; Trochu JN; Donal E; Habib G; Brochet E; Thibault H; Piriou N; Cormier B; Tribouilloy C; Guerin P; Lefèvre T; Maucort-Boulch D; Vahanian A; Boutitie F; Obadia JF
    JACC Cardiovasc Imaging; 2021 Apr; 14(4):742-752. PubMed ID: 32950444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One more option in heart failure: correction of mitral regurgitation with MitraClip
    Bini T; Agostini C; Stolcova M; Meucci F; Di Mario C
    Intern Emerg Med; 2019 Oct; 14(7):1033-1040. PubMed ID: 31297739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter Edge-to-Edge Repair in 5,000 Patients With Secondary Mitral Regurgitation: COAPT Post-Approval Study.
    Goel K; Lindenfeld J; Makkar R; Naik H; Atmakuri S; Mahoney P; Morse MA; Thourani VH; Yadav P; Batchelor W; Rogers J; Whisenant B; Rinaldi M; Hermiller J; Lindman BR; Barker CM
    J Am Coll Cardiol; 2023 Sep; 82(13):1281-1297. PubMed ID: 37730284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes Stratified by Adapted Inclusion Criteria After Mitral Edge-to-Edge Repair.
    Koell B; Orban M; Weimann J; Kassar M; Karam N; Neuss M; Petrescu A; Iliadis C; Unterhuber M; Adamo M; Giannini C; Melica B; Ludwig S; Massberg S; Praz F; Pfister R; Thiele H; Stephan von Bardeleben R; Baldus S; Butter C; Lurz P; Windecker S; Metra M; Petronio AS; Hausleiter J; Lubos E; Kalbacher D;
    J Am Coll Cardiol; 2021 Dec; 78(24):2408-2421. PubMed ID: 34886961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials?
    Senni M; Adamo M; Metra M; Alfieri O; Vahanian A
    Eur J Heart Fail; 2019 Jul; 21(7):852-861. PubMed ID: 31116485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous Mitral-Valve Intervention for Secondary Mitral Regurgitation: Data From Real-Life.
    Kaddoura R; Al-Badriyeh D; Abushanab D; Al-Hijji M
    Curr Probl Cardiol; 2023 Oct; 48(10):101889. PubMed ID: 37336309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic Outcomes After Transcatheter Leaflet Approximation in Patients With Secondary Mitral Regurgitation: The COAPT Trial.
    Asch FM; Grayburn PA; Siegel RJ; Kar S; Lim DS; Zaroff JG; Mishell JM; Whisenant B; Mack MJ; Lindenfeld J; Abraham WT; Stone GW; Weissman NJ;
    J Am Coll Cardiol; 2019 Dec; 74(24):2969-2979. PubMed ID: 31574303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results.
    Pibarot P; Delgado V; Bax JJ
    Eur Heart J Cardiovasc Imaging; 2019 Jun; 20(6):620-624. PubMed ID: 31115470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative echocardiographic assessment of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair.
    Brugger N; Kassar M; Siontis GCM; Widmer S; Okuno T; Winkel MG; Corpataux N; Gräni C; Büllesfeld L; Hunziker L; Pilgrim T; Windecker S; Praz F
    Catheter Cardiovasc Interv; 2021 Dec; 98(7):1404-1412. PubMed ID: 34406713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MitraClip: How Do We Reconcile the Inconsistent Findings of MITRA-FR and COAPT?
    Mauricio R; Kumbhani DJ
    Curr Cardiol Rep; 2019 Nov; 21(12):150. PubMed ID: 31768771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Proportionality of Secondary Mitral Regurgitation on Outcome After Transcatheter Mitral Valve Repair.
    Orban M; Karam N; Lubos E; Kalbacher D; Braun D; Deseive S; Neuss M; Butter C; Praz F; Kassar M; Petrescu A; Pfister R; Iliadis C; Unterhuber M; Lurz P; Thiele H; Baldus S; von Bardeleben RS; Blankenberg S; Massberg S; Windecker S; Hausleiter J;
    JACC Cardiovasc Imaging; 2021 Apr; 14(4):715-725. PubMed ID: 32861652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of procedural success on clinical outcome after MitraClip: Results from the MITRA-FR trial.
    Messika-Zeitoun D; Attias D; Piriou N; Iung B; Armoiry X; Trochu JN; Donal E; Habib G; Cormier B; Guerin P; Lefèvre T; Maucort-Boulch D; Boutitie F; Vahanian A; Riche B; Obadia JF
    Arch Cardiovasc Dis; 2022 Nov; 115(11):545-551. PubMed ID: 36244966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why Did COAPT Win While MITRA-FR Failed? Defining the Appropriate Patient Population for MitraClip.
    Atianzar K; Zhang M; Newhart Z; Gafoor S
    Interv Cardiol; 2019 Feb; 14(1):45-47. PubMed ID: 30858892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradox of disproportionate atrial functional mitral regurgitation and survival after transcatheter edge-to-edge repair.
    Doldi PM; Stolz L; Kassar M; Kalbacher D; Petronio AS; Butter C; von Bardeleben RS; Iliadis C; Grayburn P; Hausleiter J
    ESC Heart Fail; 2024 Aug; 11(4):2447-2450. PubMed ID: 38602287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality Associated With Proportionality of Secondary Mitral Regurgitation After Transcatheter Mitral Valve Repair: North American Mitraclip for Functional Mitral Regurgitation Registry.
    Duggal NM; Engoren M; Chadderdon SM; Rodriguez E; Morse MA; Vannan MA; Yadav PK; Morcos M; Li F; Reisman M; Garcia-Sayan E; Raghunathan D; Sodhi N; Sorajja P; Chen L; Rogers JH; Calfon MA; Kovach CP; Gill EA; Zahr FE; Chetcuti SJ; Yuan Y; Mentz GB; Lim DS; Ailawadi G
    Am J Cardiol; 2024 Feb; 213():99-105. PubMed ID: 38110022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.
    Mack MJ; Abraham WT; Lindenfeld J; Bolling SF; Feldman TE; Grayburn PA; Kapadia SR; McCarthy PM; Lim DS; Udelson JE; Zile MR; Gammie JS; Gillinov AM; Glower DD; Heimansohn DA; Suri RM; Ellis JT; Shu Y; Kar S; Weissman NJ; Stone GW
    Am Heart J; 2018 Nov; 205():1-11. PubMed ID: 30134187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.